The primary purpose of the TEBC is to develop a better understanding of the key barriers to translation and scale up of regenerative medicine technologies including challenges in efficient product design, pilot and scale up manufacturing, regulation, and reimbursement.
The TEBC group will include experts from interdisciplinary technologies that utilize cells, biomaterials, growth factors, small molecules, scaffolds, and other therapeutic agents to affect tissue growth or regeneration, ARM said in a press release.
"The primary purpose of the TEBC is to determine the unique requirements which will ultimately advance and broaden the use of clinical tissue engineered paradigms worldwide."
"Tissue engineering has tremendous potential to treat patients suffering from the loss of tissues and organs," said Jennifer Elisseeff, TEBC co-chair and Professor, Wilmer Eye Institute and Department of Biomedical Engineering, at Johns Hopkins University in Baltimore, MD.
"Through the work of the TEBC, we hope to bring tissue engineered therapeutics to patients worldwide more quickly," added Michael Abecassis, MD, co-chair of the TEBC and Founding Director of the Northwestern University Comprehensive Transplant Center.
TEBC motors, on the other hand, reportedly are well suited for extrusion applications.
A closed-loop, flux-vector inverter plus TEBC motor, and digital tach can provide complete dynamic response control, speed ranges of 100:1, and 0.05% speed regulation.